Trial Profile
A phase 3 study of SER-287 in ulcerative colitis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 26 Nov 2018
Price :
$35
*
At a glance
- Drugs SER 287 (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 26 Nov 2018 New trial record